Yuanyuan Zhang

The University of Texas Southwestern Medical Center

Papers

1

Total Citations

19

H-Index

1

About

Yuanyuan Zhang is a leading radiation oncologist whose research focuses on advancing stereotactic partial breast irradiation (S-PBI) for early-stage breast cancer. Her most-cited work, a phase 1 dose escalation study published in 2021, systematically evaluated cosmetic outcomes after 5-fraction adjuvant S-PBI in 75 women with stage 0–II breast cancer. This study demonstrated that a shorter, more convenient treatment course can achieve excellent cosmetic results, directly improving patient quality of life while maintaining oncologic safety. With 19 citations, this work has influenced clinical protocols for breast-conserving therapy. Dr. Zhang’s contributions are particularly notable for bridging the gap between radiation oncology and patient-centered outcomes, showing that dose escalation can be safely implemented without compromising breast appearance. Her research helps shape modern radiotherapy standards, offering women with early breast cancer a less burdensome treatment option. Through rigorous clinical trials, she continues to refine radiation techniques that balance efficacy with cosmetic preservation.

Research Focus

Key Achievements

1
H-Index
1
Papers
19
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer
19 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: The University of Texas Southwestern Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago